Universität Freiburg<p><a href="https://xn--baw-joa.social/tags/Prostatakrebs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Prostatakrebs</span></a>: Neu entwickelter epigenetischer <a href="https://xn--baw-joa.social/tags/Hemmstoff" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Hemmstoff</span></a> zeigt großes Potenzial. Er wirkte auch bei <a href="https://xn--baw-joa.social/tags/Krebszellen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Krebszellen</span></a>, die gegen herkömmliche Therapien resistent waren. <br><a href="https://ufr.link/prostatakrebs-hemmstoff" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">ufr.link/prostatakrebs-hemmsto</span><span class="invisible">ff</span></a><br><a href="https://xn--baw-joa.social/tags/UniFreiburg" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UniFreiburg</span></a> <a href="https://xn--baw-joa.social/tags/UniklinikFreiburg" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UniklinikFreiburg</span></a> <a href="https://xn--baw-joa.social/tags/Naturecommunications" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Naturecommunications</span></a></p>